Illumina News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

25.09.13	Illumina Applies CE Mark to Expanded MiSeqDx™ System (Businesswire)
12.09.13	FDA Approvals, Study Results, Multi-Year Collaborations, Data Presentations, and Supply Agreements - Research Report on Celgene, Amgen, Biogen Idec, Vertex, and Illumina (PR Newswire)
27.08.13	New Programs, Product Launches, Corporate Announcements and Financial Results - Research Report on Aetna, Illumina, Pharmacyclics, WellCare, and BioCryst (PR Newswire)
12.08.13	Laboratory Permits, Pending FDA Approvals, Clinical Study Presentations, and Financial Results Release - Research Report on Illumina, Theravance, Acorda, Synta, and Optimer (PR Newswire)
02.08.13	Expanding R&D Programs, Clinical Trials, Drug Applications and Acquisitions, Advancing to Help Patients with Unmet Medical Needs - Research Report on Questcor, BioMarin, Vanda, Illumina and Theravance (PR Newswire)
24.07.13	Marketing Applications, Product Launches, Commencement of Studies, Collaborations, and Release of Funding - Research Report on Biogen Idec, Illumina, Santarus, Celsion, and BioCryst (PR Newswire)
24.07.13	Illumina Shares Up 6% As Q2 Results Top View, Boosts 2013 Outlook (RTTNews)
24.07.13	After-market Movers For July 23 (AAPL, EA, VMW, TTHI, ILMN, PNRA, BRCM) (RTTNews)
23.07.13	Illumina Q2 Results Top Estimates; Acquires Advanced Liquid Logic - Quick Facts (RTTNews)
18.07.13	Complete Genomics, Illumina Settle Patent Dispute (RTTNews)
01.07.13	Illumina Applies CE Mark to MiSeqDx™ Cystic Fibrosis System (Businesswire)
19.09.12	Illumina Acquires BlueGnome, Leading Provider of Cytogenetics and In Vitro Fertilization Screening Solutions (Businesswire)
20.06.12	Illumina Announces RapidTrack Whole Genome Sequencing Service (Businesswire)
18.06.12	Illumina Files Second Patent Infringement Suit Against Complete Genomics, Inc. (Businesswire)
31.05.12	Illumina Introduces Nextera® XT DNA Sample Preparation Kits (Businesswire)
30.05.12	Illumina to Webcast Live Presentations at Upcoming Investment Conferences in June (Businesswire)
29.05.12	Queensland Centre for Medical Genomics Adopts Illumina Sequencing for Australian ICGC Program (Businesswire)
23.05.12	Cold Spring Harbor Laboratory Joins the Illumina Genome Network (Businesswire)
02.05.12	Illumina to Webcast Live Presentations at Upcoming Investment Conferences in May (Businesswire)
25.04.12	Illumina Introduces BaseSpace Apps, Solutions for Genome Informatics (Businesswire)
24.04.12	Illumina Launches MyGenome® App for iPad® (Businesswire)
23.04.12	Illumina Reports Financial Results for First Quarter of Fiscal Year 2012 (Businesswire)
16.04.12	Illumina to Announce First Quarter 2012 Results on Monday, April 23, 2012 (Businesswire)
02.04.12	Illumina Announces Preliminary Revenue for First Quarter 2012 (Businesswire)
22.03.12	Macrogen, Inc. Increases Investment in Illumina’s Next-Generation Sequencing Technology (Businesswire)
07.03.12	Illumina Introduces TruSeq® Amplicon - Cancer Panel for MiSeq® System (Businesswire)
03.03.12	Illumina to Webcast Live Presentations at Upcoming Investment Conferences in March (Businesswire)
01.03.12	Illumina Announces Outcome of First Phase of Its Patent Litigation Against LadaTech, LLC (Businesswire)
27.02.12	Illumina Comments on Roche’s Unsolicited Tender Offer Extension (Businesswire)
16.02.12	Illumina Launches Cancer Analysis Service (Businesswire)
16.02.12	Illumina Announces Favorable Patent Claim Construction Ruling in Litigation Against Complete Genomics, Inc. (Businesswire)
15.02.12	The Broad Institute Joins the Illumina Genome Network (Businesswire)
07.02.12	Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2011 (Businesswire)
07.02.12	Illumina’s Board Unanimously Rejects Roche’s Unsolicited Tender Offer as Inadequate (Businesswire)
31.01.12	Illumina Comments on Roche’s Director Nominees and Proposals (Businesswire)
27.01.12	Illumina’s Board of Directors to Review Unsolicited Tender Offer from Roche (Businesswire)
26.01.12	Illumina Adopts Stockholder Rights Agreement (Businesswire)
25.01.12	Illumina Board of Directors to Review Unsolicited Acquisition Proposal from Roche (Businesswire)
17.01.12	Illumina to Announce Fourth Quarter and Fiscal Year 2011 Financial Results on Tuesday, January 31, 2012 (Businesswire)
10.01.12	Illumina Introduces the HiSeq 2500 (Businesswire)
04.01.12	Illumina Appoints Marc Stapley as Senior Vice President and Chief Financial Officer (Businesswire)
03.01.12	Illumina to Present at the J. P. Morgan Healthcare Conference (Businesswire)
19.12.11	British Columbia Cancer Agency Joins the Illumina Genome Network (Businesswire)
19.12.11	Bloomberg Rankings Give Frontier High Marks (Businesswire)
15.12.11	Illumina Hires Laura Lauman as Vice President of Marketing (Businesswire)
23.11.11	Illumina to Present at the Piper Jaffray Health Care Conference (Businesswire)
12.10.11	Calpian, Inc. Completes Residual Purchase (Businesswire)
26.04.11	Boston Private Financial Holdings Reports First Quarter 2011 Results (Businesswire)
03.11.10	Illumina Introduces TruSeq™ Sample Prep and Exome Enrichment Kits (Businesswire)
26.10.10	Illumina Reports Financial Results for Third Quarter 2010 (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

16.12.24		Handel in New York: NASDAQ 100 zeigt sich zum Start des Montagshandels fester
13.12.24		Gewinne in New York: NASDAQ 100 mittags mit grünem Vorzeichen
11.12.24		Aufschläge in New York: NASDAQ 100 am Mittwochmittag im Plus
11.12.24		Gute Stimmung in New York: NASDAQ 100 klettert zum Handelsstart
20.11.24		Mittwochshandel in New York: NASDAQ 100 liegt letztendlich im Minus
20.11.24		Schwacher Wochentag in New York: NASDAQ 100 in der Verlustzone
20.11.24		Schwacher Handel: NASDAQ 100 schwächelt mittags
20.11.24		Schwacher Wochentag in New York: NASDAQ 100 präsentiert sich zum Handelsstart schwächer

16.12.24

Handel in New York: NASDAQ 100 zeigt sich zum Start des Montagshandels fester

13.12.24

Gewinne in New York: NASDAQ 100 mittags mit grünem Vorzeichen

11.12.24

Aufschläge in New York: NASDAQ 100 am Mittwochmittag im Plus

11.12.24

Gute Stimmung in New York: NASDAQ 100 klettert zum Handelsstart

20.11.24

Mittwochshandel in New York: NASDAQ 100 liegt letztendlich im Minus

20.11.24

Schwacher Wochentag in New York: NASDAQ 100 in der Verlustzone